Polyplus launches LipidBrick for the formulation of LNPs in mRNA therapeutics.

Polyplus, a leading provider of advanced therapeutic medicinal product manufacturing solutions from research to commercial grade, is introducing a novel cationic lipid for lipid nanoparticle (LNP) formulation in mRNA therapeutic and vaccine...

Medivir starts patient dosing in phase 2a study of fostrox in combination with Lenvima to treat hepatocellular carcinoma

Medivir AB, a pharmaceutical company focused on developing innovative cancer treatments in areas of high unmet medical need, announced that the first patient with hepatocellular carcinoma (HCC) has begun phase 2a treatment with the candidate drug...

Pfizer agrees to revise EU COVID vaccine contract

Pfizer Inc agreed to extend its COVID-19 vaccine contract from 2023 to 2026 with the European Union, the sources reported, citing people with knowledge of the matter...

Tube Investments of India to enter the pharmaceutical industry

Tube Investments of India (TII), a Murugappa group company, has identified contract development and manufacturing organisation (CDMO) and active pharmaceutical ingredients (API) as new lines of business with the ability to grow and expand. To that...

IIL, CIFA to commercially produce Aeromonas septicemia vaccine for freshwater fish

Indian Immunologicals Limited (IIL) announced a collaboration with the Central Institute of Freshwater Aquaculture (CIFA), Bhubaneswar, an Indian Council of Agricultural Research (ICAR) Institute, for the commercial development of a vaccine against..

Spanish packaging firm Inden Pharma to expand footprint in India

In order to strengthen their position in the worldwide pharmaceutical packaging market, the companies have agreed to begin certified production of bottles, containers, and closures in clean rooms in March. The companies intend to produce around...

© 2023 India Pharma Outlook. All Rights Reserved.